Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Cash is King at the moment...add to Dardani's observation...
View:
Post by rgonlyfactspls on Aug 25, 2016 11:26am

Cash is King at the moment...add to Dardani's observation...

...that ProMetic's burn rate is $22mil a qutr (from CIBC report) and the fact that they are paying an interest rate of $10.6% on 2015 loans and 16.3% and 21.8% on 2014 loan* (plus usual finder fees I assume). So ProMeitc is buying a company with $34 mil cash at pretty much the break-up price. Note: the annual interest savings alone on the $34 mil at 10% is $3.4 million. Now I better understand why Telesta's descript no longer include "focus on building shareholder value" at the end of the line. Open for competing bids...... *See page 64 of ProMetic's 2015 Financial Statements on Sedar https://www.sedar.com/GetFile.do?lang=EN&docClass=2&issuerNo=00004497&issuerType=03&projectNo=02464781&docId=3889734
Comment by saltaja on Aug 25, 2016 2:31pm
Those loans are from Thomvest, and they are convertible loans. I dont' recall all the strike prices but the latest one was around $4.8. As long as PLI share price is greater than $4.8 when the loans mature (2021 if I remember correctly) then PLI will not pay a cent. If you belive in PLI's pipeline of drugs then $4.8 in five years is not a concern. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities